U.S. flag

An official website of the United States government

NM_004168.4(SDHA):c.1423T>C (p.Cys475Arg) AND Paragangliomas 5

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Apr 21, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000663132.3

Allele description [Variation Report for NM_004168.4(SDHA):c.1423T>C (p.Cys475Arg)]

NM_004168.4(SDHA):c.1423T>C (p.Cys475Arg)

Gene:
SDHA:succinate dehydrogenase complex flavoprotein subunit A [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5p15.33
Genomic location:
Preferred name:
NM_004168.4(SDHA):c.1423T>C (p.Cys475Arg)
HGVS:
  • NC_000005.10:g.236590T>C
  • NG_012339.1:g.23350T>C
  • NM_001294332.2:c.1279T>C
  • NM_001330758.2:c.1423T>C
  • NM_004168.4:c.1423T>CMANE SELECT
  • NP_001281261.1:p.Cys427Arg
  • NP_001317687.1:p.Cys475Arg
  • NP_004159.2:p.Cys475Arg
  • LRG_315t1:c.1423T>C
  • LRG_315:g.23350T>C
  • LRG_315p1:p.Cys475Arg
  • NC_000005.9:g.236705T>C
  • NM_004168.2:c.1423T>C
  • NM_004168.3:c.1423T>C
Protein change:
C427R
Links:
dbSNP: rs781747137
NCBI 1000 Genomes Browser:
rs781747137
Molecular consequence:
  • NM_001294332.2:c.1279T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001330758.2:c.1423T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004168.4:c.1423T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Paragangliomas 5 (PPGL5)
Synonyms:
PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 5
Identifiers:
MONDO: MONDO:0013602; MedGen: C3279992; Orphanet: 29072; OMIM: 614165

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000786271Counsyl
criteria provided, single submitter

(Counsyl Autosomal Dominant Disease Classification criteria (2015))
Uncertain significance
(Apr 2, 2018)
unknownclinical testing

Counsyl_Autosomal_Dominant_Disease_Classification_criteria_(2015)_v1.pdf,

Citation Link,

SCV004045423Myriad Genetics, Inc.
criteria provided, single submitter

(Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))
Uncertain significance
(Apr 21, 2023)
unknownclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Counsyl, SCV000786271.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Myriad Genetics, Inc., SCV004045423.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024